2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave